Christian Hein · 10 November 2026 · 2 min read
Heidi and Abridge Layoffs: The AI Scribe Squeeze Begins
Heidi Health cut 18% of its staff weeks after raising US$340 million, and Abridge confirmed job cuts a day later. I expect native EHR tools to put sustained pressure on standalone scribe pricing.
TL;DR
Heidi Health cut 18% of its staff weeks after raising US$340 million, and Abridge confirmed job cuts a day later. I was always a bit skeptical of pure AI scribing as a business, and it is harder than even I thought. Epic launched its own ambient charting in February, which gives a large installed base another option. I expect native EHR tools to put sustained pressure on standalone scribe pricing.
Heidi Health cut 18% of its staff last Thursday, weeks after raising US$340 million. Abridge confirmed an undisclosed number of job cuts a day later. I was always a bit skeptical of pure AI scribing as a business. It is harder than even I thought.
Heidi cited volatile sales and rising US competition. Two of its three co-founders announced their exits the day before the cuts. Its September financing included a US$100 million Series C and US$240 million in non-dilutive growth financing from General Catalyst.
How Abridge describes its cuts
Abridge, valued at $5.3 billion after its June 2025 Series E, calls the cuts a realignment. It plans to flatten the organization, hire in priority areas and invest in new opportunities. It says it still holds more than half of the capital it has raised.
Heidi's CEO said investment had gone into the wrong teams and markets. Both companies are expanding beyond documentation. Heidi launched AI agents for pre-charting and referrals in September. Abridge describes itself as a clinician intelligence platform. The announcements do not establish which teams were cut or where the savings will go.
Epic launched its own ambient charting in February. It held about 42% of the US acute-care hospital market in 2024. That gives a large installed base another option.
Why standalone scribes face pressure
Ambient scribing is becoming table stakes. A standalone scribe has to earn its price through better performance or workflows the EHR handles poorly.
I expect native EHR tools to put sustained pressure on standalone scribe pricing. Adoption can keep growing while the business gets harder. Within a year, I would expect either significant consolidation in the sector, or an even harder push into adjacent business areas (most likely both).
Artificial Intelligence · Digital Health · Health Tech · Digital Health Startups · Commercial Strategy
Related insights
23 Oct 2025
AI in healthcare is scaling, but ambient scribes face a shake-up.
7 Aug 2025
+55% revenue growth. +50% share price. In DigitalHealth.
30 Jul 2025
Free feature or foundational platform? Investors have poured nearly $1 billion into the AI scri...
3 Nov 2026
Zocdoc and Instinct: personal AI agents as the front door to care